Francisco Javier Cabello Albendea
Direttore Finanziario/CFO presso Biocross SL
Profilo
Francisco Javier Cabello Albendea is the founder of DBP Conseil & Management SA. He currently holds the position of Investment Director at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA and Chief Financial Officer at Biocross SL.
Previously, he worked as a Director at Dendrico SL, Principal at Banco Santander SA, and Principal at Roland Berger Strategy Consultants SA. He holds an MBA from the University of Navarra and an undergraduate degree from the Instituto Catolico de Administracion y Direccion de Empresas.
Posizioni attive di Francisco Javier Cabello Albendea
| Società | Posizione | Inizio |
|---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Investitore di Private Equity | - |
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Francisco Javier Cabello Albendea
| Società | Posizione | Fine |
|---|---|---|
DBP Conseil & Management SA
 DBP Conseil & Management SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., DBP Conseil & Management SA is a management consulting company based in Madrid, Spain. The Spanish company was founded by Francisco Javier Cabello Albendea. DBP Conseil & Management was acquired by PricewaterhouseCoopers LLP on November 17, 2008. | Fondatore | - |
| BANCO SANTANDER, S.A. | Corporate Officer/Principal | - |
| Roland Berger Strategy Consultants SA | Corporate Officer/Principal | - |
Dendrico SL
 Dendrico SL Miscellaneous Commercial ServicesCommercial Services Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain. | Direttore/Membro del Consiglio | - |
Formazione di Francisco Javier Cabello Albendea
| University of Navarra | Masters Business Admin |
| Instituto Catolico de Administracion y Direccion de Empresas | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BANCO SANTANDER, S.A. | Finance |
| Aziende private | 5 |
|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
DBP Conseil & Management SA
DBP Conseil & Management SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., DBP Conseil & Management SA is a management consulting company based in Madrid, Spain. The Spanish company was founded by Francisco Javier Cabello Albendea. DBP Conseil & Management was acquired by PricewaterhouseCoopers LLP on November 17, 2008. | Commercial Services |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Health Technology |
Dendrico SL
Dendrico SL Miscellaneous Commercial ServicesCommercial Services Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain. | Commercial Services |
| Roland Berger Strategy Consultants SA |
- Borsa valori
- Insiders
- Francisco Javier Cabello Albendea
